Published in The Lancet · View the paper (DOI)
New antibody treatments for Alzheimer's disease show promise in slowing progression, but high costs, complex testing, and suboptimal care hinder their potential. Experts call for coordinated global action to reform healthcare systems, public policy, and societal attitudes.
Coverage from 2 institutions
- The Lancet: Experts outline healthcare, policy, and social changes needed to make the most of Alzheimer’s treatment breakthroughs The Lancet · Sep 22, 2025 · first to report
- Alzheimer researchers call for more diagnostics and treatment University of Gothenburg · Sep 24, 2025